ask="12.48"
ask_size="1000"
average_daily_volume="1839970"
bid="8.63"
bid_size="100"
book_value="0.02"
change="+0.38"
change_from_200_day_moving_average="3.18"
change_from_50_day_moving_average="2.07"
change_from_52_week_high="-0.36"
change_From_52_week_low="6.38"
change_in_percent="+4.55%"
close="8.74"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.75"
ebitda="-48.12M"
eps_estimate_current_year="-0.68"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="50464000"
high="8.80"
high_52_weeks="9.10"
last_trade_date="3/15/2017"
last_trade_price="8.74"
last_trade_size="60775"
last_trade_time="4:00pm"
low="8.21"
low_52_weeks="2.36"
market_capitalization="646.37M"
moving_average_200_day="5.56"
moving_average_50_day="6.67"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.78"
open="8.36"
pe_ratio="N/A"
peg_ratio="-0.64"
percent_change_from_200_day_moving_average="+57.11%"
percent_change_from_50_day_moving_average="+31.11%"
percent_change_from_52_week_high="-3.96%"
percent_change_from_52_week_low="+270.34%"
previous_close="8.36"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="398.10"
price_per_sales="23.46"
revenue="26.35M"
shares_outstanding="73955000"
short_ratio="5.21"
stock_exchange="NMS"
symbol="BCRX"
volume="1598641"
weeks_range_52="2.36 - 9.10"
